GLP-1 and GIP drugs leave human muscle cells unharmed in lab study
Direct exposure to semaglutide or GIP peptide did not cause atrophy, inflammation or mitochondrial impairment in primary human muscle cells from older adults, pointing to an…
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 4 13:12 ETSource: Bioengineer.org
From the source
Read at bioengineer.orgGLP-1 and GIP drugs leave human muscle cells unharmed in lab study
Direct exposure to semaglutide or GIP peptide did not cause atrophy, inflammation or mitochondrial impairment in primary human muscle cells from older adults, pointing to an indirect cause of lean mass loss with incretin therapies.
